Drug development and production rely on stringent quality controls, reproducibility, and verification. Biopharmaceuticals, including protein-based therapies, require extensive characterization, ...
Advancements in peptide and oligonucleotide synthesis via precision chemistry are transforming therapeutic development by ...
This episode of Chromatography Life takes a closer look at the evolving landscape of synthetic peptide drugs - one of the most compelling frontiers in biopharmaceutical analysis. Joining us is Matt ...
A potential pitfall in SRM-based quantitative proteomics could be the SRM suboptimal selectivity when low-specificity diagnostic ions are set in Q3 and/or isobaric or near-isobaric peptides occur. [3] ...
As analytical technology continues to advance, both regulatory agencies and pharmaceutical companies are keen to avail themselves of these enhancements. In the case of chromatography, evolution from ...
Label-free, gel-free, and antibody-free quantitation of Ras from complex mixture targeting exclusively proteoform-specific tryptic peptides detected in 3D-cultured and 2D-cultured NCI-H23 cells. (A) ...
Biologically active peptides play a significant part in human health. They are linked to the development of novel therapeutic healthcare products, as well as possible biological pathway markers and ...
SHANGHAI--(BUSINESS WIRE)--AmbioPharm, a worldwide leader in peptide API CDMO services, continues growth to meet capacity demands for late phase and commercial peptide production. A reliable peptide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results